Gotto, G. et al. 2020. Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC. Canadian Urological Association Journal. 14, 12 (Jun. 2020), E616–20. DOI:https://doi.org/10.5489/cuaj.6388.